You’ll find a list of relevant literature, studies and posters relating to the efficacy of NGAL testing on this page.


View Literature

Case Studies

A selection of user reports, case studies and interviews with NGAL users in both labs and clinical practice.


View Case Studies


View a range of videos discussing NGAL.


View Videos


About the NGAL Assay

Although NGAL is best known as being a biomarker of acute kidney injury (AKI), and is proving to be of great value in drug development in this context, it is now being implicated in as a key component of a number of other pathways and disease states. These include cancer, inflammation and sepsis.

Our sensitive and reliable ELISA based NGAL assays provide a reliable and sensitive means of measuring NGAL levels in both pharmaceutical and medical research settings.

Read More